Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Clark

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Journal of Molecular Graphics & Modelling|January 6, 2001
Visualizing substructural fingerprintsR D Clark, D E Patterson, F Soltanshahi, et al.
British Journal of Pharmacology|August 1, 1995
Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivoR M Eglen, D W Bonhaus, L G Johnson, et al.
Developmental Medicine and Child Neurology|September 30, 1999
Behavioral style of young boys with fragile X syndromeD D Hatton, D B Bailey, M Q Hargett-Beck, et al.
Ophthalmology|November 1, 1983
Spontaneous carotid-cavernous fistula and the Ehlers-Danlos syndromesM K Farley, R D Clark, M K Fallor, et al.
Journal of Medicinal Chemistry|August 2, 1996
Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptorsD E Patterson, R D Cramer, A M Ferguson, et al.
Neuroscience|March 4, 2008
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose bingesM H Baumann, R D Clark, F H Franken, et al.
International Psychogeriatrics|January 1, 1995
Neuroleptic use and behavioral disturbance in nursing homes: a 1-year studyL C Burton, B W Rovner, P S German, et al.
Neuropharmacology|April 1, 1997
The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigationD J Fontana, S E Daniels, E H Wong, et al.
Journal of Traumatic Stress|June 23, 1999
Divalproex in posttraumatic stress disorder: an open-label clinical trialR D Clark, J M Cañive, L A Calais, et al.
Journal of Medicinal Chemistry|October 1, 1983
Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]sJ M Caroon, R D Clark, A F Kluge, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Journal of Molecular Graphics & Modelling|January 6, 2001
Visualizing substructural fingerprintsR D Clark, D E Patterson, F Soltanshahi, et al.
British Journal of Pharmacology|August 1, 1995
Pharmacological characterization of two novel and potent 5-HT4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivoR M Eglen, D W Bonhaus, L G Johnson, et al.
Developmental Medicine and Child Neurology|September 30, 1999
Behavioral style of young boys with fragile X syndromeD D Hatton, D B Bailey, M Q Hargett-Beck, et al.
Ophthalmology|November 1, 1983
Spontaneous carotid-cavernous fistula and the Ehlers-Danlos syndromesM K Farley, R D Clark, M K Fallor, et al.
Journal of Medicinal Chemistry|August 2, 1996
Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptorsD E Patterson, R D Cramer, A M Ferguson, et al.
Neuroscience|March 4, 2008
Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose bingesM H Baumann, R D Clark, F H Franken, et al.
International Psychogeriatrics|January 1, 1995
Neuroleptic use and behavioral disturbance in nursing homes: a 1-year studyL C Burton, B W Rovner, P S German, et al.
Neuropharmacology|April 1, 1997
The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigationD J Fontana, S E Daniels, E H Wong, et al.
Journal of Traumatic Stress|June 23, 1999
Divalproex in posttraumatic stress disorder: an open-label clinical trialR D Clark, J M Cañive, L A Calais, et al.
Journal of Medicinal Chemistry|October 1, 1983
Synthesis and antihypertensive activity of a series of spiro[1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizine-2,5'-oxazolidin-2'-one]sJ M Caroon, R D Clark, A F Kluge, et al.
Pageof 12